Yoga Market Is Booming Worldwide 2024-2030

 Yoga Market Growth & Trends

The global yoga market size is expected to reach USD 200.35 billion by 2030, registering a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Consumers are becoming increasingly aware of stress relief and mental health benefits associated with yoga which has led to a shift beyond physical fitness. The surge in health consciousness, coupled with a shift towards holistic lifestyles will drive the market growth. Studies demonstrating the effectiveness of yoga in managing various health conditions have fueled the demand for restorative yoga, therapeutic yoga, prenatal yoga, and hatha yoga. According to the WHO, every year hypertension affects over 1 billion adults worldwide. The population suffering from hypertension accounts for up to 45% of the adult population. By 2025, the number of people with hypertension is expected to increase by 15-20%, reaching almost 1.5 billion.

The integration of technology has allowed the yoga industry to expand its reach. Advancements such as online platforms, mobile apps, virtual reality (VR), and wearable tech have made yoga more accessible, enabling individuals to practice their homes. Moreover, the availability of digital platforms and mobile applications that offer virtual yoga classes has significantly widened access and participation. These platforms offer convenience and accessibility, allowing individuals to practice yoga remotely, access various classes, and learn from renowned instructors regardless of location. For instance, in September 2023, Cult. Fit, an India-based health and fitness brand, announced the launch of Evolve Yoga, a new evidence-based, transformative yoga format designed to enhance flexibility and mobility.

The popularity of yoga among high-profile celebrities and athletes is also influencing public perception and increasing its popularity. Moreover, busy lifestyles and increased stress drive demand for convenient and accessible fitness options like yoga. In addition, there has been an increase in the demand for yoga retreats and vacations focused on yoga. This trend provides tourism destinations with an opportunity to cater to the growing demand for yoga-related travel experiences. According to GWI, the global wellness tourism industry generated USD 651 billion in 2022, and it is expected to grow at a rate of 16.6% annually, with a projected value of USD 1.4 trillion in 2027.

Factors such as busy work schedules and rising disposable incomes in both developed and developing economies are allowing individuals to spend more on their health and well-being. This has led to a rise in investment in yoga classes, retreats, and accessories. In addition, the availability of free online resources, discount studios, and community classes has made yoga accessible to budget-conscious individuals. According to the CDC’s National Diabetes Statistics Report for 2022, around 37.3 million people, or 11.3% of the U.S. population, have diabetes. Research has shown that yoga can effectively improve glycemic control, reduce stress, and enhance overall well-being for individuals with diabetes.

Employers have realized the benefits of yoga in reducing stress, improving employee well-being, and enhancing productivity. This has led to the inclusion of yoga sessions as part of workplace wellness programs. Moreover, yoga studios partner with local organizations to encourage the participation of yoga practitioners and promote community well-being. For instance, in July 2022, CorePower Yoga announced a collaboration with Thompson Hotels to help people maintain fitness and wellness as part of their lifestyle and travel experiences. The rooftop workout classes are rooted in the mindfulness of yoga, and designed to transform the minds and bodies of guests, CorePower Yoga members, and locals.

Request a free sample copy or view report summary: Yoga Market Report

Yoga Market Report Highlights

• Offline yoga course dominated the market in 2023. Offline yoga courses offer the advantage of direct interaction with a qualified yoga instructor who can provide personalized guidance and feedback, aiding in proper form and preventing injuries. These offerings are targeted at specific demographics or focused on specialized areas such as yoga for stress relief, therapeutic yoga, prenatal yoga, and yoga for athletes
• Demand from male segment is expected to surge in the forecast period. Increasing awareness of its physical and mental benefits led to a significant rise in male participation. Men are becoming more aware of the diverse health benefits of yoga beyond traditional fitness routines. They appreciate yoga for its ability to improve flexibility, build strength, enhance balance, and complement other forms of exercise
• 30-50 years age group segment held the majority revenue share in 2023. Yoga becomes a means of stress reduction, fitness maintenance, and mental relaxation for individuals within this age bracket. Moreover, increased awareness of the benefits of managing chronic health conditions is supplementing the segment growth
• Asia Pacific is anticipated to grow with the highest CAGR over the forecast period. This is due to factors such as rising disposable incomes and government initiatives promoting yoga through policies and initiatives for raising awareness of its benefits. Growing middle-class population, particularly in countries including China, India, South Korea, and Japan creates disposable income for premium yoga experiences and wellness activities

Access Press Release@ https://www.grandviewresearch.com/press-release/global-yoga-market

Yoga Market Segmentation

Grand View Research has segmented the global yoga market based on delivery mode, end-use, age group, and region:

Yoga Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Online Yoga Course
• Offline Yoga Course
• Yoga Accreditation Training Programs
• Others

Yoga End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Male
• Female

Yoga Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Below 18 Years
• 18-29 Years
• 30-50 Years
• Above 50 Years

Yoga Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in the Yoga Market

• CorePower Yoga
• Honor Yoga
• Pure Yoga
• Glo Digital, Inc.
• YogaOne
• YogaSix
• Yoga Pod
• MoreYoga
• Power Yoga Canada
• Flyogi LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Low Profile Additives Market Predicted to Witness Steady Growth During the Forecast Period

 Low Profile Additives Market Growth & Trends

The global low profile additives market size is anticipated to reach USD 1.24 billion by 2030, registering a CAGR of 5.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rapid growth of the end-use industries, such as construction, automotive, and electronics, is expected to drive product demand. Moreover, rising demand for shrink & bulk molding compounds (SMCs/BMCs) pultruded plastics and resin transfer molding (RTM) products in automobiles as well as construction and infrastructural activities is likely to propel product demand in coming years. Products, such as polyvinyl acetate (PVAc), polymethyl methacrylate (PMMA), polystyrene (PS), and high-density polyethylene (HDPE), are used in a variety of applications, such as sheet and bulk molding compounds, pultrusion, and RTM.

Growing end-use industries around the world, particularly in emerging nations, are likely to fuel industry expansion. Key companies maintain a high market competition with the implementation of various strategic initiatives, such as new polymer launch, polymerion expansion, and mergers & acquisitions. For instance, in October 2023, Schaeffler Technologies AG & Co. KG acquired Aerosint SA from Desktop Metal in the U.S., bolstering its market position in additive manufacturing technologies. The new company, Schaeffler Aerosint SA, will be brought into the Schaeffler Group as a new location for Schaeffler Special Machinery.

Moreover, rapidly expanding automotive industry is expected to be a major factor driving the industry growth. Growing demand for sheet molded compounds from the automotive industry, on account of their low weight and surface finish, is anticipated to drive the demand for low profile additives. The demand for sheet molded parts has been increasing due to their application in outer shells of passenger vehicles as they are lightweight and easy to produce. Moreover, sheet molding is economically viable. Producers can reduce expenses in all aspects of the production, such as labor and waste. Such factors are anticipated to have a positive impact on market growth.

Request a free sample copy or view report summary: Low Profile Additives Market Report

Low Profile Additives Market Report Highlights

• Growing end-use industries, such as construction, automotive, and electronics, are expected to drive product demand
• High demand for SMC/BMC pultruded plastics and RTM products in automobiles as well as construction & infrastructural activities will also propel product demand
• SMC/BMC composite solutions enable the production of lighter components, hence lowering the environmental impact as well as fuel emissions
• Furthermore, tight tolerances can be generated immediately without the need for post-processing, resulting in not only cost savings but also greater profitability
• The Asia Pacific regional market is expected to grow considerably owing to the augmentation and modernization of automotive industry coupled with new technological advances
• Furthermore, several initiatives launched by the governments of various countries in this region to attract investments from international companies are projected to drive region’s growth
• Key low profile additives include PVAc, PMMA, PS, and HDPE. Advantageous properties of PVAc as a low profile additive, such as improved surface finish and almost-zero shrinkage, will boost its demand in various compounding techniques

Access Press Release@ https://www.grandviewresearch.com/press-release/global-low-profile-additives-lpa-market

Low Profile Additives Market Segmentation

Grand View Research has segmented the global low profile additives market based on product, function, application, and region:

Low Profile Additives Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Polyvinyl Acetate (PVAc)
• Polymethyl Methacrylate (PMMA)
• Polystyrene (PS)
• Polyurethane (PU)
• High-density Polyethylene (HDPE)

Low Profile Additives Function Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Anti-shrinkage
• Pigmentation

Low Profile Additives Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Shrink & Bulk Molding Compounds (SMC/BMC)
• Pultrusion
• Resin Transfer Molding
• Others

Low Profile Additives Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • The Netherlands
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Malaysia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates (UAE)
  • South Africa

List of Key Players of Low Profile Additives Market

• Wacker Chemie AG
• INEOS AG
• Polynt S.p.A.
• Vin Industries
• BASF SE
• Altana
• Polychem Limited
• SWANCOR
• LyondellBasell Industries Holdings B.V.
• Aromax Technology Corporation
• Interplastic Corporation
• Synthomer PLC
• AOC, LLC
• Mechemco
• Taak Resin Co.
• NOF Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Baby Products Market to Incur Considerable Upsurge During 2024– 2030: Grand View Research Inc.

 Baby Products Market Growth & Trends

The global baby products market is expected to reach USD 475.15 billion by 2030, and is expected to grow at a CAGR of 5.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the primary factors driving market expansion is the shift in consumer preferences toward high-quality, utility-driven, and premium baby products. In addition, the significant increase in awareness among parents about baby health and hygiene is also driving market expansion. Many medical practitioners recommend parents to use baby personal care products regularly to nourish their baby's skin, which boosts market growth.

Many parents are seeking hygienic and moisture-based products, such as creams and wipes, to avoid skin infections and treat diaper rashes. Moreover, parents are seen to be spending more on child care than ever before, especially after the pandemic. For instance, Child Care Aware of America (CCAoA) found that the national annual average price of child care for 2022 was USD 10,853. Moreover, the Move.org figures reported that in April 2021, parents in the District of Columbia are spending 26.3% of their income on infant care, followed by 24.4% in Massachusetts, 21.9% in Indiana, and 21.3% in New York as of March 2021.

The baby safety & convenience segment is projected to grow substantially during the forecast years. A rise in the number of car accidents has been driving the demand for baby car seats that are also fitted with unique features. This feature involves car seats such as anti-rebound bars to keep the seats steady in case of collision and a foam layer with energy absorption. An increasing number of internet users, a fast-paced lifestyle, and the penetration of e-commerce platforms are projected to boost the online distribution of these products. Detailed product descriptions, product comparison features, product ratings & reviews, and easy exchange and refund options further augment sales of baby care products via this channel.

Mass baby products is expected to hold a market share of 74.1% in the market by 2030. Affordability is a key driver for the increased demand for mass baby products. As parents seek cost-effective options without compromising on quality, mass baby products become an attractive choice. These products are often competitively priced, making them accessible to a larger consumer base. Furthermore, the growing emphasis on value for money and the increasing number of price-sensitive consumers have further fueled the demand for mass baby products as parents are looking to seek solutions that meet their baby's needs without stretching their budgets.

Baby products are sold through various distribution channels such as hypermarkets & supermarkets, specialty stores, pharmacies & drugstores, online, and departmental stores, among others. The sales of baby products through specialty stores is expected to grow at a CAGR of 6.3% from 2024 to 2030. Specialty stores focusing on baby products offer a wide range of specialized items tailored specifically for infants and young children. These stores employ knowledgeable staff who can provide expert advice and guidance to parents, helping them make informed purchasing decisions. The curated product selection ensures that parents have access to high-quality, age-appropriate, and unique baby products.

Moreover, the opening of new specialty stores specifically for infants and toddlers is further expected to augment the market growth. For instance, in April 2023, Babies "R" announced the opening of its first baby store at American Dream in the U.S., scheduled for mid-summer. This new store aims to cater to the needs of new and expecting parents by providing interactive experiences such as a stroller test track. In addition, the store will feature a baby registry lounge, a nursery design center, a learning center for private events and workshops, and a comfortable zone where parents can feed or change their babies.

The Asia Pacific region is expected to grow at a CAGR of 6.6% from 2024 to 2030. The rising population and increasing disposable income in many countries within the region have led to higher spending on baby products. According to the 2022 World Bank data, more than 45% of babies in the age group of 0 years to 24 months reside in the Asia Pacific region, further contributing to the increasing demand for baby products. In the Asia Pacific region, India's baby products industry is projected to grow at a CAGR of 7.2% over the forecast period. India has a large and growing population, including a significant number of young parents. The increasing number of babies being born in India contributes to the overall demand for baby products. According to the World Mapper statistics of 2022, India registered the highest number of births, reaching 23 million.

Request a free sample copy or view report summary: Baby Products Market Report

Baby Products Market Report Highlights

• Asia Pacific held a market share of 43.1% in 2023. Changing lifestyles owing to rising standards of living is the primary factor that is expected to propel the market in the region. Furthermore, consumer awareness regarding nutritional diet for babies and the importance of safety & convenience products is likely to boost regional sales
• The baby cosmetics & toiletries segment held the largest share of 33.5% in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030. Along with offering benefits such as refreshed skin and instant hydration, these products are hassle-free and easy to use. They provide quick solutions for fighting off issues related to infections, dryness, and diaper rashes. A large number of informed parents are opting for products that contain anti-bacterial, anti-fungal, and antioxidant properties that are beneficial to skin driving the growth of the segment
• The premium baby products to grow at the fastest CAGR of 7.0% from 2023 to 2030. The increasing disposable income and changing consumer preferences have led to a growing demand for high-quality and premium baby products. Parents are willing to invest more in products that offer superior quality, safety, and comfort for their babies
• The hypermarkets & supermarkets accounted for a share of 36.8% in 2023. These retail formats offer a wide range of baby products, catering to the diverse needs of parents. They provide a convenient one-stop shopping experience, allowing parents to find everything they need in one place driving the sales of baby products through these channels

Access Press Release@ https://www.grandviewresearch.com/press-release/global-baby-products-market

Baby Products Market Segmentation

Grand View Research has segmented the baby products market based on product, type, distribution channel, and region.

Baby Product Outlook (Revenue, USD Million, 2018 - 2030)

• Baby Cosmetics & Toiletries
  • Baby Skin Care Products
  • Bath Product
  • Baby Hair Care Products
  • Baby Diapers & Wipes
  • Other Cosmetics & Toiletries
• Baby Food
  • Baby Milk Products
  • Frozen Baby Food
  • Baby Juice
  • Baby Food Snacks
  • Baby Food Cereals
  • Other Baby Food
• Baby Safety & Convenience
  • Baby Strollers
  • Baby Car Seats
  • Baby Monitors
  • Baby Proofing Products
  • Others
• Baby Toys and Play Equipment
  • Rattles & Teethers
  • Stuffed Animals & Plush Toys
  • Baby Walkers
  • Others
• Baby Clothing
  • Bodysuits
  • Tops
  • Bottoms
  • Others
• Baby Nursery & Furniture
  • Cribs & Coats
  • Bassinets
  • High Chairs
  • Others
• Baby Feeding & Nursing
  • Bottles & Nipples
  • Breast Pumps
  • Bottle Warmers & Sterilizers
  • Others

Baby Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Mass
• Premium

Baby Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hypermarkets & Supermarkets
• Specialty Stores
• Pharmacies & Drugstores
• Online
• Others

Baby Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE

List of Key Players in the Baby Products Market

• Johnson & Johnson
• Kimberly-Clark Corporation
• The Procter & Gamble Company
• Unilever
• Britax
• Chicco
• Dorel Industries
• Beiersdorf AG
• Fujian Hengan Group
• Nestlé S.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Graphene Market Poised to Expand at a Robust Pace of $1.60 Billion Over 2030: Grand View Research Inc.

Graphene Market Growth & Trends

The global graphene market is anticipated to reach USD 1.60 billion by 2030 and is anticipated to expand at a CAGR of 35.1% during the forecast period, according to a new report by Grand View Research, Inc. The increasing penetration of graphene in various end-use industries such as automotive, electronics, aerospace, construction, and medical is expected to boost the market’s demand. In addition, rising demand from various multi-national companies and research institutions for research and development purposes is further expected to escalate market growth.

The ongoing research and development in graphene production is also expected to boost product utilization in various applications. For instance, the flash joule heating technique identified in 2020 showed promising results. Studies have demonstrated that the carbon-carbon bonds are reorganized into a graphene structure when significant amounts of electricity is passed through any carbon source. By using this method, any carbon-containing material, such as coal or even trash, can be converted into numerous pounds of high-quality graphene at a comparatively low cost.

Current manufacturing methods are capital-intensive as well as require high energy and resource costs. While current amounts of graphene available in market can meet demands of researchers, full commercialization market is still in early phases. The process of developing a novel material, its manufacturing, and application for a company involves many pounds of graphene powder and hundreds of graphene sheets, as well as a significant amount of time and work. This could pose a challenge for the manufacturers of graphene.

The market is governed by a complex regulation that encompasses safety, health, and environmental concerns. The manufacturing, handling, and application of graphene materials are heavily regulated by national and international regulatory authorities. These strict guidelines include potential health risks and environmental impact while ensuring the proper production and usage. Market participants are anticipated to benefit from compliance with these regulations by gaining a competitive edge over their competitors.

The market is highly dynamic and exhibits intense competition, owing to the presence of various small and medium-scale manufacturers. Key industry participants emphasize investments in research & development and product innovations in order to gain a competitive edge.

Request a free sample copy or view report summary: Graphene Market Report

Graphene Market Report Highlights

• Graphene oxide dominated the technology segment with more than 47.0% share in 2023 owing to its superior characteristics, including excellent thermal and electrical conductivity, transparency, permeability, and strength.
• Reduced graphene oxide segment is expected to grow at the fastest CAGR over the forecast period.
• Electronic component segment held the largest market share in 2023. Composite application is anticipated to witness fastest growth over the forecast period.
• The automotive end-use segment dominated the market in 2023. The growth of this industry can be attributed to the rising disposable income and increasing purchasing power of the middle-income population in emerging economies.
• Asia Pacific dominated the market owing to the presence of a large number of manufacturers and consumers. Increasing production volumes in various sectors including automobile, marine, defense, and aerospace are expected to drive the market in this region over the forecast period.
• Market players operating in market include Nanoxplore Inc.; Telga Group, Directa Plus S.p.A, Graphene Laboratories, Inc., GRAPHENE SQUARE INC, and ACS Material, Applied Graphene Materials, 2D Carbon Graphene Material Co., Ltd., Thomas Swan & Co. Ltd.
• In March 2023, Directa Plus S.p.A. announced the partnership with Colombo Industrie Tessili. Both companies produced a new innovative fabric, obtained using a graphene-based dyeing treatment. The key characteristic of this new fabric is its thermal capability, which allows for consistent temperatures and heat dispersion. The dyeing technique of Graphene Plus on the fabric imparts antistatic properties required by the military and workplace, as well as antimicrobial, antibacterial, and antiviral properties to the cloth.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-graphene-market

Graphene Market Segmentation

Grand View Research has segmented the global graphene market on the basis of product, application, end-use, and region:

Graphene Product Outlook (Volume, Tons; Revenue, USD Million; 2018 - 2030)

• Graphene Nanoplatelets
• Graphene Oxide
• Reduced Graphene Oxide
• Monolayer Graphene
• Bulk Graphene
• Others

Graphene Application Outlook (Volume, Tons; Revenue, USD Million; 2018 - 2030)

• Paints & Coatings
• Electronic Components
• Composites
• Batteries
• Solar Panels
• Others

Graphene End-use Outlook (Volume, Tons; Revenue, USD Million; 2018 - 2030)

• Automotive
• Medical
• Aerospace
• Defense
• Concrete Industry
• Tires
• Others

Graphene Region Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players in the Graphene Market

• Applied Graphene Materials
• 2D Carbon Graphene Material Co., Ltd.
• Thomas Swan & Co. Ltd.
• Graphene Laboratories, Inc.
• Graphensic AB
• GRAPHENE SQUARE INC
• AMO GmbH
• Talga Group
• ACS Material
• BGT Materials Limited, Ltd.
• CVD Equipment Corporation
• Directa Plus S.p.A.
• Grafoid Inc
• Graphenea
• NanoXplore Inc.
• HAYDALE GRAPHENE INDUSTRIES PLC
• Zentek Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Therapy Market Expected to Deliver Dynamic Progression By 2030

Cell Therapy Market Growth & Trends

The global cell therapy market size is expected to reach USD 20.07 billion by 2030, expanding at a CAGR of 22.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market players are witnessing an increasing interest in the development of advanced therapies that are based on tissue, genes, or cells. Research communities and companies continue to make large investments in the culturing and isolation of a broad range of cell types, such as keratinocytes, chondrocytes, cartilage, stem, dermal papilla, & epithelial cells for the development of novel therapies.

Regulatory authorities such as FDA play a crucial role in the growth of the market by undertaking initiatives related to the development and approval of advanced treatment development as well as restriction of unregulated treatments. In addition, direct cellular reprogramming is attracting interest as a cutting-edge treatment approach because of its advantages such as efficacy and security.

On the other hand, an increase in the number of clinical trials related to advanced therapies is expected to boost the market growth in the coming years. According to data obtained from the American Society of Gene & Cell Therapy, in Q1 2022, 32 non-genetically modified cellular therapeutics trials were initiated, and 69% of these were in the non-oncology arena. Moreover, according to ClinicalTrials.gov, more than 1800 active cellular therapies are under clinical trial.

Furthermore, key companies operating in the market are undertaking several strategic initiatives such as various agreements, new launches, and expansion to strengthen their market presence. For instance, in May 2022, the University of Pennsylvania's personalized cellular therapy was approved for the treatment of individuals with relapsed or resistant follicular lymphoma.

Moreover, in April 2021, Bristol Myers Squibb declared that U.S. FDA approved its Breyanzi (lisocabtagene maraleucel), a novel CAR T treatment for adults with R/R large B-cell lymphoma. In the pivotal trial for 3L+ LBCL, TRANSCEND NHL 001, Breyanzi showed a 73% overall response rate and a 54% complete response (CR) rate.

Request a free sample copy or view report summary: Cell Therapy Market Report

Cell Therapy Market Report Highlights

• The autologous therapy segment dominated the market with the largest revenue share of 91.22% in 2023, owing to increasing adoption of this therapy type coupled with lower risk of life-threatening complications
• The allogenic therapy segment is expected to grow significantly in the coming years owing to factors such as high pricing and growth in stem cell banking. Moreover, many companies are preparing to shift their business toward allogenic cell therapy product development
• Oncology therapeutic area captured the largest market share in 2023, owing to the increasing adoption of advanced cell therapies in the treatment of various types of cancers
• Cell therapy are also under the investigation for musculoskeletal disorders and has great potential for market growth
• North America dominated the market owing to the strong regulatory framework, presence of bodies like the International Society for Cellular Therapy, and presence of key operating companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-therapy-market

Cell Therapy Market Segmentation

Grand View Research has segmented the global cell therapy market based on therapy type, therapeutic area, and region.

Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)

• Allogeneic Therapies
  • Stem Cell Therapies
    • Hematopoietic Stem Cell Therapies
    • Mesenchymal Stem Cell Therapies
  • Non-Stem Cell Therapies
    • Keratinocytes & Fibroblast-based Therapies
    • Others
  • Autologous Therapies
    • Stem Cell Therapies
      • BM, Blood, & Umbilical Cord-derived Stem Cells
      • Adipose Derived Cells
      • Others
    • Non-Stem Cell Therapies
      • T-Cell Therapies
        • CAR T Cell Therapy
        • T Cell Receptor (TCR)-based
      • Others

Cell Therapy Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Cardiovascular Disease (CVD)
• Musculoskeletal Disorders
• Dermatology
• Others

Cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
• Rest of the World

List of Key Players in Cell Therapy Market

• Novartis AG
• Gilead Sciences, Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc
• JCR Pharmaceuticals Co., Ltd.
• JW Therapeutics
• Atara Biotherapeutics
• Anterogen Co., Ltd.
• MEDIPOST
• BIOMEDICS

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antibiotic Resistance Market Trends, Demand, Production, Analysis and Forecast to 2030: Grand View Research Inc.

 Antibiotic Resistance Market Growth & Trends

The global antibiotic resistance market size is expected to reach USD 12.48 billion by 2030, registering a CAGR of 5.27% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of antibiotic-resistant infections due to misuse or overuse of antibiotics is a major factor attributing to market growth. Moreover, the increasing patient base across the globe and high costs associated with the treatment of diseases is anticipated to boost the market growth over the forecast period.

The prevalence of gram-negative infections is increasing at an alarming rate. These infections have lesser treatment options available in the market. The high unmet needs result in high demand for new therapies and, therefore, small and medium-sized pharmaceutical companies are actively involved in the development of novel treatment options. Moreover, the government and other organizations are also aiding research activities to drive the development of innovative therapies.

Multiple mid-level biotechnology companies have entered the arena with targeted therapies for antibiotic-resistant infections. Various manufacturers are developing therapies, especially for drug-resistant infections, that target a smaller population subset.

The U.S. government in alliance with BARDA is supporting several companies to boost the development of new therapies for antibiotic-resistant diseases. BARDA has also been associated with pharmaceutical companies such as GSK; Tetraphase; Basilea; Astra Zeneca; and many more. Many countries and international organizations have formed dedicated groups or alliances to monitor and study the pattern of drug-resistant infections.

For instance, the WHO has introduced the Global Antimicrobial Resistance Surveillance System (GLASS) to monitor antibiotic-resistant infections at a global level. Similarly, the Public Health Agency of Canada has introduced the Canadian Antimicrobial Resistance Surveillance System (CARSS) to study drug-resistant infections pattern at the country level.

However, according to a review published by WHO in March 2023, the antibiotics pipeline activities are limited, with only 12 new antibiotics being approved between 2017 and 2021. The review further stated that there are only 27 new candidates under development, out of which only 6 are considered “innovative” enough to be capable of overcoming antibiotic resistance as defined by WHO.

Request a free sample copy or view report summary: Antibiotic Resistance Market Report

Antibiotic Resistance Market Report Highlights

• In 2023, cUTI accounted for the largest market share and is anticipated to maintain its dominance in the global market in the coming years
• Combination drugs are expected to grow at the fastest CAGR over the forecast period
• North America dominated the antibiotic resistance industry in 2023. The target goals set by the U.S. national action plan in response to the significant burden of resistant gram-positive and negative infections is the key factor driving the market
• Asia Pacific is set to witness the fastest growth over the forecast period due to excessive consumption of antibiotics, advancements in technology, and growing awareness about antibiotic resistance testing, treatment, & management of the same.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antibiotic-resistance-market

Antibiotic Resistance Market Segmentation

Grand View Research has segmented the global antibiotic resistance market based on disease, pathogen, drug class, mechanism of action, distribution channel, and region:

Antibiotic Resistance Disease Outlook (Revenue, USD Million, 2018 - 2030)

• cUTI (Complicated Urinary Tract Infections)
• CDI (Clostridioides difficile Infection)
• ABSSSI (Acute bacterial skin and skin structure infections)
• HABP (Hospital-acquired bacterial pneumonia)
• CABP (Community-acquired pneumonia)
• cIAI (Complicated intra-abdominal infection)
• BSI (Bloodstream infection)

Antibiotic Resistance Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

• coli
• pneumoniae
• aeruginosa
• aureus
• baumannii
• pneumoniae
• influenzae
• difficile
• faecium

Antibiotic Resistance Drug Class Outlook (Revenue, USD Million, 2018 - 2030)

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination therapies
• Cephalosporins
• Others

Antibiotic Resistance Mechanism of Action Outlook (Revenue, USD Million, 2018 - 2030)

• Protein Synthesis Inhibitors
• Cell Wall Synthesis Inhibitors
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Others

Antibiotic Resistance Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Antibiotic Resistance Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Antibiotic Resistance Market

• Melinta Therapeutics
• Basilea Pharmaceutica Ltd.
• Tetraphase Pharmaceuticals
• Theravance Biopharma
• WOCKHARDT
• Paratek Pharmaceuticals, Inc.
• Seres Therapeutics
• ACHAOGEN, INC.
• Entasis therapeutics
• AbbVie
• Merck & Co. Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Liver Metastases Treatment Market Factors, Rising Demand, Driving Growth by 2030

 Liver Metastases Treatment Market Growth & Trends

The global liver metastases treatment market is expected to reach USD 2.66 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.3% from 2024 to 2030. Rising prevalence of target disease, advanced stage diagnosis for cancer in developing countries, and increasing number of products approvals is expected to drive the industry growth.

Colorectal cancer, breast cancer, and lung cancer are some of the key types that metastasize to the liver. The incidence of colorectal cancer is expected to increase from 1.88 million in 2020 to 2.45 million in 2030. Whereas the incidence of breast cancer is expected to increase from 2.26 million in 2020 to 2.74 million in 2030. The rising incidence of these primary indications is expected to drive space growth.

Majority of the cancer cases in low and middle-income countries are diagnosed at advanced stages where the availability of therapeutic options is low. The lack of availability of early diagnostics methods combined with uncertain reimbursement scenario for diagnostics are major reasons for delayed diagnosis. The advanced/metastatic stage of diagnosis provide lucrative growth opportunities in this space.

On the other hand, if cancers are diagnosed at advanced stages particularly in developing nations and LMICS, the treatment rate at such advanced stages is significantly less, due to unavailability of products and proper reimbursement. This factor is expected to restrain space growth.

Request a free sample copy or view report summary: Liver Metastases Treatment Market Report

Liver Metastases Treatment Market Report Highlights

• By treatment type, the targeted therapy segment dominated the market with a share of 56.52% to the presence of approved drugs with a price higher than traditional chemotherapy.
• In 2023, colorectal cancer dominated the liver metastases treatment market with a share of 40.55%. Around 25-30% of all colorectal cancers metastasize to the liver. The availability of various treatment options for CCLM further contributed to the segments’ dominance.
• Based on distribution channel, the market was dominated by the hospital pharmacies segment with a share of 60.07% in 2023. The high rate of hospitalization for the treatment of liver metastases is one of the major factors for the dominance of this segment.
• By region, North America has a high revenue share in the global liver metastases treatment market in 2023. However, Asia Pacific is expected to be the fastest growing region during the forecast period.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-liver-metastases-treatment-market

Liver Metastases Treatment Market Segmentation

Grand View Research has segmented the global liver metastases treatment market report based on treatment type, primary cancer, distribution channel, and region:

Liver Metastases Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Chemotherapy
• Targeted Therapy
• Immunotherapy

Liver Metastases Treatment Primary Cancer Outlook (Revenue, USD Million, 2018 - 2030)

• Colorectal Cancer
• Breast Cancer

Liver Metastases Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital Pharmacies
• Specialty Pharmacies

Liver Metastases Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List Of Key Players in the Liver Metastases Treatment Market

• Hoffmann-La Roche Ltd.
• AstraZeneca
• Eli Lilly and Company
• Bayer AG
• Ono Pharmaceutical
• Pfizer, Inc.
• Bristol-Myers Squibb Company
• Cadila Pharmaceuticals Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Plastics In Electrical And Electronics Market Size Is Anticipated To Reach USD 53.27 Billion by 2030

 Plastics In Electrical And Electronics Market Growth & Trends

The global plastics in electrical and electronics market size is anticipated to reach USD 53.27 billion by 2030 and it is projected to grow at a CAGR of 5.2% from 2024 to 2030, according to a new report by Grand View Research, Inc.

The global electrical & electronics market is vast and dynamic. It encompasses a wide range of products and services. The growth of this market across the world is driven by multiple factors, including ongoing technological advancements, rising consumer demand for electrical components and electronic devices, and increasing urbanization. Surging disposable income and increasing demand for energy efficiency are factors contributing to the growth of electrical & electronics market worldwide.

An expansion of electronics industry, driven by the emergence of 5G, IoT, and AI technologies, has driven the demand for plastics in electrical & electronics market. Moreover, increasing demand from building & construction industry globally is anticipated to boost demand for plastics across electrical & electronics industry.

Players across the market maintain a high market competition with the implementation of various strategic initiatives such as new Polymer launch, Polymerion expansion, merger & acquisitions, among others. For instance, in may 2023, SABIC announced its expansion of high-heat ULTEM resin portfolio by introducing new glass fibre-reinforced grades that would deliver high flow, custom colour ability, and high strength. This Polymer is well suited for electronic components such as fibre optics and electrical connectors.

The market is witnessing a transformation of the value chain from a linear economy into a circular one. Major players in the market are transitioning to a circular economy to obtain more sustainable solutions and minimize their dependency on crude oil in the future. This trend has led to a rise in the demand for renewable raw materials such as vegetable oil, and plastic waste to produce plastics in recent years.

The rising number of data centers across the world has increased the demand for electronic devices, electrical connectors, laptops, desktops, printing devices, server racks, and other such equipment that are developed from plastics. Polycarbonate is a prime plastic utilized across the IT server industry as it leads to the development of highly durable, flexible, and lightweight twin walls, wall-mounted enclosures, aisle containment panels, cooling system housings, etc.

Moreover, the surging demand for data servers owing to the prevailing trend of cloud computing has led companies such as Facebook, Inc., Amazon.com, Inc., Twitter, and Microsoft Corporation to install sever systems for data storage. This has contributed to the demand for polycarbonate (PC) and other plastics for use in the global IT server industry.

Request a free sample copy or view report summary: Plastics In Electrical And Electronics Market Report

Plastics In Electrical And Electronics Market Report Highlights

• The expansion of the electronics industry, driven by the emergence of 5G, IoT, and AI technologies, has driven the demand for plastics in electrical & electronics market. Moreover, increasing demand from building & construction industry across the globe is anticipated to boost the demand for plastics across electrical & electronics industry
• Based on polymer, PVC is commonly used for insulation, cable sheathing, and wire coatings. Its fire resistance and good electrical properties make it an ideal material for ensuring safety and reliability in electrical systems
• Smartphones, tablets, and computers are ubiquitous in consumer electronics, providing communication, entertainment, and productivity functions. Medical devices such as diagnostic, monitoring, and treatment systems rely on electronic components for accurate and reliable performance
• The demand for high-quality medical devices across countries such as China, India, and Singapore, is increasing on account of the rising healthcare expenditure which again increases in demand for the market as majority of the medical devices requires polymers, PCBs, electrical casings and others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-plastics-electrical-electronics-market

Plastics In Electrical And Electronics Market Segmentation

Grand View Research has segmented the global plastics in electrical and electronics market report based on polymer, application, and region:

Plastics In Electrical And Electronics Polymer Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Acrylonitrile butadiene styrene (ABS)
• Polypropylene (PP)
• Polyurethane (PU)
• Polyvinyl Chloride (PVC)
• Polyethylene (PE)
• Polycarbonate (PC)
• Polymethyl Methacrylate (PMMA)
• Polyamide (PA)
• Others

Plastics In Electrical And Electronics Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Wires & cables
• Electrical insulation
• Printed circuit boards (PCBs)
• Electronic devices
• Electrical connectors
• Others

Plastics In Electrical And Electronics Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Italy
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates (UAE)
  • South Africa

List of Key Players In the Plastics In Electrical And Electronics Market

• BASF SE
• Ensinger, Inc.
• Covestro AG
• TORAY INDUSTRIES, INC.
• Radici Partecipazioni SpA
• RTP Company
• LOTTE Chemical Corporation
• Trinseo S.A.
• SABIC
• Evonik Industries AG
• Mitsubishi Chemical Group Corporation
• Arkema
• LyondellBasell Industries Holdings B.V.
• Celanese Corporation
• Exxon Mobil Corporation
• LG Chem
• INEOS Group
• CHIMEI

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Advanced Therapy Medicinal Products CDMO Market to Partake Significant Development During 2024 to 2030: Grand View Research Inc.

 Advanced Therapy Medicinal Products CDMO Market Growth & Trends

The global advanced therapy medicinal products CDMO market size is expected to reach USD 18.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 18.92% from 2024 to 2030, owing to rising clinical trials for advanced therapy medicinal products and the increasing awareness among researchers about the benefits of advanced therapies, driving the advanced therapy medicinal products (ATMP) CDMO market growth. Tissue engineering has greatly benefited in recent years from technological development. The damaged tissues and organ function are replaced or restored using this technique. Similarly, gene and cell therapy are attracting a lot of patients for the treatment of rare diseases, whose incidence is rising globally.

With rising demand for robust disease treatment therapies, key players have focused their efforts to ramp up research and development for effective gene therapies that target the cause of disorder at a genomic level. According to ASGCT, the number of cell and gene therapies in the U.S. pipeline programs (phase I-III trials) increased from 483 in 2021 to 529 in 2022. Furthermore, the FDA delivers constant support for innovations in the gene therapy field via a number of policies with regard to product manufacturing. In January 2020, the agency released six final guidelines on the manufacturing and clinical development of safe & efficient gene therapy products.

Moreover, awareness about ATMP treatment options is being driven by initiatives aimed at informing the public about the benefits of these products, which, in turn, is leading to increased adoption of advanced therapies and fueling market growth for CDMOs. For instance, Alliance for Regenerative Medicine Foundation for Cell and Gene Medicine prioritizes activities for increasing public awareness through educational programs, underlining the clinical & societal benefits of regenerative medicine.

Increasing clinical trial activity along with new product launches generates growth opportunities for the market. As of 2022, there are 1451 ATMPs in preclinical stages and 535 are being studied in Phase 1 to 3 studies. Since August 2020, EMA has approved six of these additional ATMPs, and five more will be approved by 2023. In the UK, there were approximately 168 advanced therapy medicinal product trials underway in 2021, up from the 154 studies reported the year before, which is a 9% increase. 2021 saw a 32% increase in phase 1 trials, indicating a significant shift from experimental medicines to first-in-human studies.

On the other hand, key players are undertaking various strategic initiatives to introduce novel products, which is expected to propel market growth. For instance, in March 2021, CureVac N.V. signed a partnership agreement with Celonic Group, engaged in the manufacture of CVnCoV, CureVac’s mRNA-based COVID-19 vaccine candidate. CureVac's COVID-19 vaccine candidate is manufactured at Celonic's commercial manufacturing unit for ATMPs and biologics in Heidelberg, Germany. Under the terms of the commercial supply agreement, the Celonic facility could produce over 100 million doses of CVnCoV.

Request a free sample copy or view report summary: Advanced Therapy Medicinal Products CDMO Market Report

Advanced Therapy Medicinal Products CDMO Market Report Highlights

• The gene therapysegment held the largest share of over 49.2% in 2023. Increase in financial support and rise in number of clinical trials for gene therapies are driving demand for the gene therapy segment.
• The cell therapysegment is expected to show lucrative growth over the forecast period. The field of cellular therapeutics is constantly advancing with inclusion of new cell types, which, in turn, provides ample opportunities for companies to enhance their market positions.
• The oncology segment accounted for the largest revenue share in 2023. The segment’s dominance is attributed to disease burden, strategic initiatives undertaken by key players, and availability of advanced therapies used for treating various cancer indications.
• The phase I segment dominated the market in 2023 due to growing R&D activities and increasing number of human trials for advanced therapies.
• North America dominated the overall market share of 49.0% in 2023. This can be attributed to increasing outsourcing activities and rising awareness about advanced therapy.
• The Asia Pacific region is expected to grow at the fastest CAGR over the forecast period due to the increasing demand for novel ATMPs and rising R&D activities to develop novel therapies.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-advanced-therapy-medicinal-product-cdmo-market

Advanced Therapy Medicinal Products CDMO Market Segmentation

Grand View Research has segmented the global advanced therapy medicinal products CDMO market report based on product, phase, indication, and region:

Advanced Therapy Medicinal Products CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)

• Gene Therapy
• Cell Therapy
• Tissue Engineered
• Others

Advanced Therapy Medicinal Products CDMO Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Advanced Therapy Medicinal Products CDMO Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Cardiology
• Central nervous system
• Musculoskeletal
• Infectious disease
• Dermatology
• Endocrine, metabolic, genetic
• Immunology & inflammation
• Ophthalmology
• Hematology
• Gastroenterology
• Others

Advanced Therapy Medicinal Products CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Advanced Therapy Medicinal Products CDMO Market

• Celonic
• Bio Elpida
• CGT Catapult
• Rentschler Biopharma SE
• AGC Biologics
• Catalent
• Lonza
• WuXi Advanced Therapies
• BlueReg
• Minaris Regenerative Medicine
• Patheon

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.